Skip to main content
All lobbying filings

THORN RUN PARTNERS

Lobbying for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Compounding Pharmacy Supplier/Provider

 Filing 1st Quarter - Termination
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 17, 2025
Income
$30,000.00
What the client paid this registrant for the period.
Client based in
Texas
Representation ended
Feb 28, 2025
The registrant reported terminating its work for this client.

Official filing document

 Lobbyists on this filing 2
  • JESSIE HOWE BRAIRTON
    Previously held: Senior Legislative Asst/Legislative Asst, Rep. Lamar Smith; LC/Asst, Senate Special Aging Committee
  • GARY PALMQUIST
    Previously held: Legislative Director: Rep. Dennis Cardoza, Rep. Bob Clement, Rep. Ken Bentsen

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 2
  • HR 167
    Patient Access to Urgent-Use Pharmacy Compounding Act of 2023
  • HR 3810
    Drug Origin Transparency Act of 2023
 Lobbying activity 3
Health Issues

Issues related to drug supply chain and drug shortages. Issues related to bioidentical compounded hormones.

Pharmacy

Issues related to the Drug Quality and Security Act, Compounding Pharmacy, Reimbursement, and Patient Access, animal compounding, and H.R.167 - Patient Access to Urgent-Use Pharmacy Compounding Act of 2023. H.R.3810 - Drug Origin Transparency Act of 2023.

Medicare/Medicaid

Medicare Part D reimbursement of bulk substances.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem